Related Experiment Video

Updated: Jun 25, 2026

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
08:07

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

Published on: April 28, 2023

Monitoring the autophagy pathway in cancer

Frank C Dorsey1, Meredith A Steeves, Stephanie M Prater

  • 1Department of Cancer Biology, The Scripps Research Institute, Scripps-Florida, Jupiter, Florida, USA.

Methods in Enzymology
|February 17, 2009
PubMed

Insights

Autophagy, a cell survival pathway, is a promising cancer treatment target. New methods to monitor this pathway are introduced, addressing challenges in developing targeted therapies.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Autophagy is a fundamental cell survival mechanism activated by metabolic stress, preventing bioenergetic collapse.
  • The autophagy pathway plays a critical role in tumor progression and maintaining the malignant state.
  • Conventional chemotherapeutics often activate autophagy, complicating treatment strategies.

Purpose of the Study:

  • To review the multifaceted roles of autophagy in cancer.
  • To introduce novel methodologies for monitoring autophagic activity.
  • To address the need for specific autophagy-targeting agents in cancer therapy.

Main Methods:

  • Literature review on autophagy's role in cancer.
  • Development of novel ex vivo and in vivo methods to monitor autophagic activity.
  • Analysis of challenges in targeting the autophagy pathway.

Main Results:

  • Autophagy is implicated in both promoting and suppressing tumor development.
  • Existing chemotherapeutics generally induce autophagy, suggesting a need for inhibitors.
  • Novel monitoring techniques provide insights into autophagic flux in cancer models.

Conclusions:

  • Targeting autophagy presents a promising strategy for cancer treatment, particularly for resistant cancers.
  • Development of specific autophagy inhibitors is crucial.
  • Advanced methods for monitoring autophagy are essential for evaluating therapeutic efficacy.

More Related Videos

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...